Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Awaiting price reaction for this filing.
Piramal Pharma has informed stock exchanges about its upcoming schedule of meetings with analysts and institutional investors during June 2025. The meetings include a Bank of America Healthcare Tour group meeting in Mumbai on June 5, a virtual Goldman Sachs Investor Field Trip on June 17, the Kotak Investor Conference in London on June 23-24, and additional investor meetings in London on June 25. All meetings are group or one-on-one sessions with investors. This is a routine disclosure under SEBI listing regulations, and dates may change due to scheduling exigencies.
This is a routine compliance filing with no material financial information. Active engagement with top global investors like Bank of America and Goldman Sachs, along with the London roadshow, signals ongoing investor outreach which may support visibility and liquidity for the stock.